Answers are grounded in this paper and cite their sources.
Defines mechanisms that activate fibroblasts in chronic kidney disease, suggesting new treatment targets.
Our study defines a prominent mechanism of myofibroblast activation and supplies a potential avenue for targeting fibroblast Smo to treat chronic kidney disease.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: